Is 6606.HK stock a buy after recent weakness?

6606.HK stock shows an oversold bounce setup but carries elevated PE **58.92**. Meyka AI grades it **B (HOLD)**. Consider short-term trades with tight stops rather than large buys until fundamentals improve.

What is the Meyka AI price forecast for 6606.HK stock?

Meyka AI's forecast model projects **HK$21.48** for 6606.HK stock over 12 months, implying **+51.89%** from **HK$14.14**. Forecasts are model-based projections and not guarantees.

Which risks could stop an oversold bounce in 6606.HK stock?

Key risks are stretched receivables, negative operating margins, and sector weakness. A failure to deliver clinical or sales catalysts would likely cap any bounce in 6606.HK stock.

How should traders size positions for an oversold bounce in 6606.HK stock?

Use modest position sizes, a stop below **HK$13.70**, and targets near **HK$21.48**. Re-evaluate after earnings or material news to avoid overexposure in this volatile setup.

HK Stocks

HK$14.14 pre-market 6606.HK New Horizon Health HKSE 20 Mar 2026: Oversold bounce, +51.89%

ByDanny Kontos March 20, 2026

6606.HK stock trades at HK$14.14 pre-market on 20 Mar 2026, after a 37.57% YTD slide that sets an oversold bounce setup. The immediate price range shows a day low HK$13.76 and day high HK$17.80, with volume 5,342,000.00 shares changing hands. This note frames fundamentals, sector context, technicals, and a practical oversold-bounce playbook for Hong Kong (HKSE) traders.